Illumina's revenue and expenses in Q4 2024 showed a business-focused trend with a significant emphasis on core Illumina and product segments. Here's a detailed analysis:
- Revenue Segmentation:
- Core Illumina: Contributed the most to the revenue, with $3.23 billion. This indicates a strong performance from Illumina's core sequencing and array products.
- Product: Followed closely behind with $3.66 billion, reflecting the continued strength of Illumina's product offerings.
- Service and Other: Generated $716 million, which, while lower than the core segments, still represents a substantial contribution to the overall revenue.
- GRAIL: Contributed $55 million, which, along with the separate $55 million from GRAIL, shows the growing impact of Illumina's subsidiaries.
- Eliminations: Had a negative impact with -$15 million, suggesting some internal adjustments or cancellations within the reporting period.
| | |
|---|
| 20240101-2024 | Amortization of Acquired Intangible Assets | 0 |
| 20240101-2024 | Amortization of Acquired Intangible Assets | 0 |
View null result

- Net Income and Operating Expenses:
- Illumina reported a net income of $187 million for the quarter1. This indicates profitability despite the revenue segmentation, which is a positive signal for the company's operational efficiency.
- The operating expenses are not provided, but the net income can be used as a proxy to infer that Illumina managed to cover its expenses effectively, possibly even exceeding expectations given the revenue figures.
- Overall Performance:
- The total revenue for the quarter was $4.33 billion1. This is a notable figure that underscores Illumina's robust market presence and its ability to generate substantial revenue.
- The absence of specific operating expense data prevents a comprehensive analysis of the company's cost management. However, the net income of $187 million, along with the revenue figures, suggests that Illumina is managing its business effectively to convert revenue into profit.
In conclusion, Illumina's Q4 2024 financials reflect a company that is performing strongly in terms of revenue generation, with a particular strength in its core sequencing and array products. The company's ability to manage its business segments effectively and report a net income highlights its operational efficiency and profitability.